Suppr超能文献

非酒精性脂肪性肝炎肝移植患者中供体年龄与感染风险的预后关系:UNOS 数据库分析。

The prognostic relationship between donor age and infectious risk in liver transplant patients with nonalcoholic steatohepatitis: Analysis of UNOS database.

机构信息

Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD, United States of America.

Department of Medicine, Tufts University School of Medicine, Boston, MA, United States of America.

出版信息

Dig Liver Dis. 2023 Jun;55(6):751-762. doi: 10.1016/j.dld.2023.01.160. Epub 2023 Feb 15.

Abstract

BACKGROUND & AIMS: We investigate the effects of advancing donor age on the prognostic outcomes of patients with NASH who undergo liver transplant (LT), with a specialized attention toward infectious outcomes post-LT.

METHODS

The UNOS-STAR registry was used to select 2005 to 2019 LT recipients with NASH, who were stratified by donor age into the following categories: recipients with younger donors (less than 50 years of age-reference), quinquagenarian donors, sexagenarian donors, septuagenarian donors, and octogenarian donors. Cox regression analyses were conducted for all-cause mortality, graft failure, infectious causes of death.

RESULTS

From a total of 8888 recipients, the quinquagenarian, septuagenarian, and octogenarian donor cohorts showed greater risk of all-cause mortality (quinquagenarian: aHR 1.16 95%CI 1.03-1.30; septuagenarian: aHR 1.20 95%CI 1.00-1.44; octogenarian: aHR 2.01 95%CI 1.40-2.88). With advancing donor age, there was an increased risk of death from sepsis (quinquagenarian: aHR 1.71 95% CI 1.24-2.36; sexagenarian: aHR 1.73 95% CI 1.21-2.48; septuagenarian: aHR 1.76 95% CI 1.07-2.90; octogenarian: aHR 3.58 95% CI 1.42-9.06) and infectious causes (quinquagenarian: aHR 1.46 95% CI 1.12-1.90; sexagenarian: aHR 1.58 95% CI 1.18-2.11; septuagenarian: aHR 1.73 95% CI 1.15-2.61; octogenarian: aHR 3.70 95% CI 1.78-7.69).

CONCLUSION

NASH patients who receive grafts from elderly donors exhibit higher risk of post-LT mortality, especially due to infection.

摘要

背景与目的

我们研究了供体年龄的增加对接受肝移植(LT)的 NASH 患者预后的影响,特别关注 LT 后感染的结果。

方法

利用 UNOS-STAR 登记处,选择了 2005 年至 2019 年接受 NASH 的 LT 受者,按供体年龄分为以下几类:年轻供者(<50 岁-参考)、50 岁供者、60 岁供者、70 岁供者和 80 岁供者。对所有原因死亡率、移植物失功、感染性死亡原因进行 Cox 回归分析。

结果

在总共 8888 名受者中,50 岁供者、70 岁供者和 80 岁供者队列的全因死亡率风险更高(50 岁供者:aHR 1.16,95%CI 1.03-1.30;70 岁供者:aHR 1.20,95%CI 1.00-1.44;80 岁供者:aHR 2.01,95%CI 1.40-2.88)。随着供体年龄的增加,败血症导致的死亡风险增加(50 岁供者:aHR 1.71,95%CI 1.24-2.36;60 岁供者:aHR 1.73,95%CI 1.21-2.48;70 岁供者:aHR 1.76,95%CI 1.07-2.90;80 岁供者:aHR 3.58,95%CI 1.42-9.06)和感染性原因(50 岁供者:aHR 1.46,95%CI 1.12-1.90;60 岁供者:aHR 1.58,95%CI 1.18-2.11;70 岁供者:aHR 1.73,95%CI 1.15-2.61;80 岁供者:aHR 3.70,95%CI 1.78-7.69)。

结论

接受老年供体移植物的 NASH 患者 LT 后死亡率较高,特别是因感染导致的死亡率较高。

相似文献

5
Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes.
Dig Dis Sci. 2024 Sep;69(9):3513-3553. doi: 10.1007/s10620-024-08522-6. Epub 2024 Jul 16.
6
Reappraisal of Donor Age in Liver Transplantation: NASH as a Potential Target to Safely Utilize Old Liver Grafts.
Transplantation. 2024 Jul 1;108(7):e110-e120. doi: 10.1097/TP.0000000000004865. Epub 2023 Nov 22.
7
Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors.
Transpl Int. 2022 Aug 25;35:10489. doi: 10.3389/ti.2022.10489. eCollection 2022.
9
Using old liver grafts for liver transplantation: where are the limits?
World J Gastroenterol. 2014 Aug 21;20(31):10691-702. doi: 10.3748/wjg.v20.i31.10691.
10
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
J Hepatol. 2019 Aug;71(2):313-322. doi: 10.1016/j.jhep.2019.04.011. Epub 2019 May 7.

引用本文的文献

本文引用的文献

1
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.
Front Med (Lausanne). 2021 Apr 14;8:615978. doi: 10.3389/fmed.2021.615978. eCollection 2021.
3
Regression of portal hypertension: underlying mechanisms and therapeutic strategies.
Hepatol Int. 2021 Feb;15(1):36-50. doi: 10.1007/s12072-021-10135-4. Epub 2021 Feb 5.
4
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
World J Gastroenterol. 2020 May 7;26(17):1993-2011. doi: 10.3748/wjg.v26.i17.1993.
5
Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019.
JAMA Netw Open. 2020 Feb 5;3(2):e1920294. doi: 10.1001/jamanetworkopen.2019.20294.
6
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Ann Hepatol. 2019 Nov-Dec;18(6):855-861. doi: 10.1016/j.aohep.2019.06.014. Epub 2019 Sep 6.
7
Hallmarks of Aging in the Liver.
Comput Struct Biotechnol J. 2019 Aug 7;17:1151-1161. doi: 10.1016/j.csbj.2019.07.021. eCollection 2019.
8
Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2759-2768.e5. doi: 10.1016/j.cgh.2019.04.033. Epub 2019 Apr 17.
9
Macrophages in the Aging Liver and Age-Related Liver Disease.
Front Immunol. 2018 Nov 30;9:2795. doi: 10.3389/fimmu.2018.02795. eCollection 2018.
10
Effects of aging on liver microcirculatory function and sinusoidal phenotype.
Aging Cell. 2018 Dec;17(6):e12829. doi: 10.1111/acel.12829. Epub 2018 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验